VintaBio Information

Biotherapeutics manufacturing partner enabling scalable production while maintaining product quality. VintaBio is a viral vector development and manufacturing partner supporting biotech and pharmaceutical companies advancing AAV, LVV, adenoviral, Vero-based, vaccine, and other viral vector programs into clinical development. We specialize in adherent manufacturing across preclinical, IND-enabling, process development, and clinical-stage production. Our approach enables scalable production, combining biological fidelity with manufacturing efficiency to deliver: • Higher quality and more consistent product output • Greater control over production conditions and timing • Reduced impurity burden and downstream complexity • Reliable clinical supply and predictable timelines • Scalable production without increasing manufacturing footprint We partner with development, CMC, and technical operations teams to reduce scale-up risk, strengthen process control, and accelerate programs toward the clinic — particularly in rare and genetically defined diseases where speed and reliability matter most. Headquartered in the Philadelphia Navy Yard — a leading hub for cell and gene therapy innovation — VintaBio is focused on delivering scalable, high-quality viral vector manufacturing to support clinical success and long-term therapeutic impact. To learn more: www.vintabio.com